Abstract
An 83-year-old woman with a history of non-central nervous system lymphoma presented to our hospital with a 2-week history of progressively slurred speech and 3 days of new-onset right-sided weakness. She had been diagnosed with malignant lymphoplasmacytic lymphoma 1 year prior and had received 8 months of rituximab, the last dose being 3 months prior to admission.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
